Tango Therapeutics: I'm Not Buying Into Latest Rally, Despite PRMT5 Promise
Source: SeekingAlpha
2026-03-06 16:02:05 ET
Investment Overview
The stock of Tango Therapeutics, Inc. ( TNGX ) surged in value yesterday, rising from ~$12.4, to $17.4 per share, a gain of ~43%, as the Boston, Massachusetts based biotech reported its Q4 and annual earnings, and shared business updates....
Read the full article on Seeking Alpha
For further details see:
Tango Therapeutics: I'm Not Buying Into Latest Rally, Despite PRMT5 Promise
Tango Therapeutics Inc.
NASDAQ: TNGX
TNGX Trading
0.48% G/L:
$16.59 Last:
601,796 Volume:
$16.95 Open:
TNGX Latest News
March 06, 2026 05:33:52 pm
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TNGX Stock Data
$1,709,052,323
80,160,147
2.71%
43
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
